Drug
Bms 945429
Bms 945429: highest development phase Phase 2, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMS-945429 NCT01490450 | Phase 2 | Arthritis, Psoriatic |
Latest
No recent events.
Follow Bms 945429 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.